(Q44373592)

English

Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA).

scientific article published in March 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). (English)

1 reference

Europe PubMed Central

2 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

allergic rhinitis

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

2 December 2017

Giorgio Walter Canonica

4

object named as

Giorgio W Canonica

1 reference

Europe PubMed Central

2 December 2017

3

object named as

Claus Bachert

1 reference

Europe PubMed Central

2 December 2017

10

object named as

Joaquim Mullol

1 reference

Europe PubMed Central

2 December 2017

Stephen R Durham

6

object named as

Stephen R Durham

1 reference

Europe PubMed Central

2 December 2017

1

object named as

Jean Bousquet

1 reference

Europe PubMed Central

2 December 2017

F. Estelle R. Simons

13

object named as

F Estelle R Simons

1 reference

Europe PubMed Central

2 December 2017

author name string

Paul Van Cauwenberge

2

1 reference

Europe PubMed Central

2 December 2017

Pascal Demoly

5

1 reference

Europe PubMed Central

2 December 2017

Wystske Fokkens

7

1 reference

Europe PubMed Central

2 December 2017

Richard Lockey

8

1 reference

Europe PubMed Central

2 December 2017

Eli O Meltzer

9

1 reference

Europe PubMed Central

2 December 2017

Robert M Naclerio

11

1 reference

Europe PubMed Central

2 December 2017

Antonio M Vignola

14

1 reference

Europe PubMed Central

2 December 2017

John O Warner

15

1 reference

Europe PubMed Central

2 December 2017

European Academy of Allergy and Clinical Immunology (EAACI)

16

1 reference

Europe PubMed Central

2 December 2017

Allergic Rhinitis and its Impact on Asthma (ARIA)

17

1 reference

Europe PubMed Central

2 December 2017

publication date

1 March 2003

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

58

1 reference

Europe PubMed Central

2 December 2017

3

1 reference

Europe PubMed Central

2 December 2017

192-197

1 reference

Europe PubMed Central

2 December 2017

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

21 January 2018

H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

21 January 2018

The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

21 January 2018

Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

21 January 2018

Fexofenadine reduces nasal congestion in perennial allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

21 January 2018

Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7-10 December 1999, Geneva, Switzerland

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

21 January 2018

Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

21 January 2018

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

21 January 2018

Cushing's syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroids

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

21 January 2018

Assessing the effect of intranasal steroids on growth

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

21 January 2018

Fluticasone propionate aqueous nasal spray in pregnancy rhinitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

21 January 2018

Effects of antihistamines in adult asthma: a meta-analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Corticosteroid-sparing effect of azelastine in the management of bronchial asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and pathologic methods to assess the long-term safety of nasal corticosteroids. French Triamcinolone Acetonide Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2003.00054.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1398-9995.2003.00054.X

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44373592&oldid=2140898758"